Generation and characterization of a bivalent protein boost for future clinical trials: HIV-1 subtypes CR01_AE and B gp120 antigens with a potent adjuvant-Reference-Cited by-同舟云学术

Generation and characterization of a bivalent protein boost for future clinical trials: HIV-1 subtypes CR01_AE and B gp120 antigens with a potent adjuvant

Published:2018-04-26 Issue:4 Volume:13 Page:e0194266
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Wen Yingxia,Trinh Hung V.^ORCID,Linton Christine E.,Tani Chiara,Norais Nathalie,Martinez-Guzman DeeAnn,Ramesh Priyanka,Sun Yide,Situ Frank,Karaca-Griffin Selen,Hamlin Christopher,Onkar Sayali,Tian Sai,Hilt Susan,Malyala Padma,Lodaya Rushit,Li Ning,Otten Gillis,Palladino Giuseppe,Friedrich Kristian,Aggarwal Yukti,LaBranche Celia,Duffy Ryan,Shen Xiaoying,Tomaras Georgia D.,Montefiori David C.,Fulp William,Gottardo Raphael,Burke Brian,Ulmer Jeffrey B.,Zolla-Pazner Susan,Liao Hua-Xin,Haynes Barton F.,Michael Nelson L.,Kim Jerome H.,Rao Mangala,O’Connell Robert J.,Carfi Andrea,Barnett Susan W.

Funder

Bill and Melinda Gates Foundation

Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., and the U.S. Department of Defense (DOD)

Swiss National Science Foundation (SNSF)

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference92 articles.

1. UNAIDS. http://www.unaids.org/sites/default/files/country/documents/THA_narrative_report_2015.pdf.

2. UNAIDS. http://aidsinfo.unaids.org.

3. WHO. http://www.who.int/hiv/topics/vaccines/Vaccines/en/.